Maria F Gonzalez-Lara
Overview
Explore the profile of Maria F Gonzalez-Lara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
949
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gonzalez-Lara M, Roman-Montes C, Diaz-Lomeli P, Hernandez-Ceballos W, Morales-Camilo L, Cervantes-Sanchez A, et al.
J Clin Microbiol
. 2025 Jan;
63(3):e0137124.
PMID: 39887202
Correct, rapid, and reliable filamentous fungi identification is crucial for timely diagnosis and therapy. We compared the performance of the FFLv4.0 MALDI Biotyper and MSI-2 to identify filamentous fungi from...
2.
Aceves-Sanchez B, Rojas-Castaneda E, Ponce-de-Leon A, Lopez-Iniguez A, Rangel-Cordero A, Sanchez E, et al.
Med Mycol Case Rep
. 2024 Dec;
46:100686.
PMID: 39703621
We describe two cases of possible healthcare-associated mucormycosis in liver transplant recipients. Mucorales may be acquired from environmental sources such as contaminated medical equipment, grafts or procedure related. Gastrointestinal mucormycosis...
3.
Beltran-Reyes P, Ostrosky-Zeichner L, Gonzalez-Lara M
Curr Opin Infect Dis
. 2024 Sep;
37(6):437-442.
PMID: 39259683
Purpose Of Review: Recently, fungal meningitis outbreaks have occurred in association with neuraxial and epidural anesthesia in immunocompetent patients. Herein, we describe the course of those outbreaks, their diagnosis, treatment,...
4.
Rajme-Lopez S, Tello-Mercado A, Ortiz-Brizuela E, Martinez-Guerra B, Tamez-Torres K, Roman-Montes C, et al.
Cancer Rep (Hoboken)
. 2024 Aug;
7(8):e2129.
PMID: 39158198
Background: Few studies regarding infectious causes of febrile neutropenia (FN) in Mexico are available. Aims: We aimed to describe clinical and microbiological characteristics of FN episodes during induction chemotherapy in...
5.
Rajme-Lopez S, Martinez-Guerra B, Roman-Montes C, Tamez-Torres K, Tello-Mercado A, Tepo-Ponce K, et al.
Ther Adv Infect Dis
. 2024 Mar;
11:20499361241236582.
PMID: 38545451
Background: Even though worldwide death rates from coronavirus disease 2019 (COVID-19) have decreased, the threat of disease progression and death for high-risk groups continues. Few direct comparisons between the available...
6.
Quinonez-Flores A, Martinez-Guerra B, Roman-Montes C, Tamez-Torres K, Gonzalez-Lara M, Ponce-de-Leon A, et al.
Antibiotics (Basel)
. 2024 Feb;
13(2).
PMID: 38391562
Background: First-line treatments for methicillin-susceptible (MSSA) bacteraemia are nafcillin, oxacillin, or cefazolin. Regional shortages of these antibiotics force clinicians to use other options like dicloxacillin and cephalotin. This study aims...
7.
Roman-Montes C, Bojorges-Aguilar S, Diaz-Lomeli P, Cervantes-Sanchez A, Rangel-Cordero A, Martinez-Gamboa A, et al.
Front Fungal Biol
. 2023 Sep;
3:855914.
PMID: 37746186
Among critically ill patients, COVID-19-associated pulmonary aspergillosis (CAPA) is a challenging complication. The recommended diagnostic methods for this disease are bronchoalveolar lavage (BAL) culture and galactomannan (GM) testing, which were...
8.
Rajme-Lopez S, Gonzalez-Lara M, Rangel-Cordero A, Ponce-de-Leon A
Med Mycol Case Rep
. 2023 Apr;
40:33-35.
PMID: 37063702
Immunocompromised patients are at risk of opportunistic infections. This is a 67-year-old woman with systemic sclerosis and knee osteoarthritis who underwent left total knee arthroplasty in 2009. In 2018 she...
9.
Martinez-Guerra B, Medrano-Borromeo C, Gonzalez-Lara M, Roman-Montes C, Tamez-Torres K, Rajme-Lopez S, et al.
Rev Invest Clin
. 2022 Nov;
74(5):268-275.
PMID: 36328004
Background: Prognostic factors in previously healthy young patients with COVID-19 remained understudied. Objectives: The objective of the study was to identify factors associated with in-hospital death or need for invasive...
10.
Rajme-Lopez S, Martinez-Guerra B, Zalapa-Soto J, Roman-Montes C, Tamez-Torres K, Gonzalez-Lara M, et al.
Open Forum Infect Dis
. 2022 Oct;
9(10):ofac502.
PMID: 36285176
Background: Early treatment of coronavirus disease 2019 (COVID-19) with remdesivir in high-risk patients, including those with immunosuppression of different causes, has not been evaluated. The objective of this study was...